Shareholders' Equity and Equity incentive Plan (Tables)

12 Months Ended

Dec. 31, 2024

Convertible Preferred Shares, Shareholders’ Deficit And Equity Incentive Plan [Abstract]

Schedule of share option activity of equity incentive plan

	Options Outstanding
	Outstanding Share Options			Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
	(in thousands, except share, life and per share data)
Balance as of December 31, 2023		7,761,657		$	2.56		5.44	$	287,694
Granted		-
Exercised		(1,497,879	)		1.83				78,941
Forfeited		(4,514	)		3.51
Balance as of December 31, 2024		6,259,264		$	2.74		4.51	$	324,172
Exercisable as of December 31, 2024		6,259,264		$	2.74		4.51	$	324,172

Schedule of restricted stock unit activity

	Amount of RSU’s			Weighted average grant date fair value
Unvested as of December 31, 2023		1,957,057		$	31.15
Granted		1,493,325			34.29
Vested		(1,147,821	)		32.60
Forfeited		(213,616	)		30.26
Unvested as of December 31, 2024		2,088,945		$	32.74

Schedule of share-based compensation expense

	Year Ended December 31,
	2022		2023		2024
	(in thousands)
Cost of revenue	$	262	$	639	$	929
Research and development		21,970		26,266		17,291
Sales and marketing		3,877		4,259		5,836
General and administrative		12,800		13,796		15,102
Total share-based compensation expense	$	38,909	$	44,960	$	39,158

Schedule of ordinary shares reserved for future issuance

	December 31,
	2023		2024
Outstanding share options		7,761,657		6,259,264
Unvested RSU’s		1,957,057		2,088,945
Remaining shares available for future issuance under the Incentive Plan		18,370,826		17,099,715
Total shares of Ordinary Shares reserved		28,089,540		25,447,924